2009•Unpublished venueRequires access

The Clinical Study on Risperidone Replacing Clozapine in the Treatment of Chronic Schizophrenia

XU Hong-ju

Open publisher page 0 citations

Abstract

Objective To compare the efficacy and safety of rispredone and Clozapine in the treatment of chronic schizophrenia. Methods 60 inpatients with chronic schizophrenia who took clozapine were treated by risperidone for 12 weeks. Effects and side effects were assessed with PANSS and TESS respectively before and after 4, 8, 12 weeks treatment. Results Risperdone was as effective as clozapine in the treatment of schizophrenia, after 12 weeks treatment there were no significant differences in the positive score of PANSS and total score (t=1.52, t=1.59, P0.05), and there was significant differences in the negative score of PANSS (t=6.13, P 0.01), Risperidone replacement could further improve negative symptoms and less side effects than clozapine. Conclusion Rispredone replacing clozapine is effective in the treatment of chronic schizophrenia with less side effects and good compliance.

About this research paper

What this paper is about

Objective To compare the efficacy and safety of rispredone and Clozapine in the treatment of chronic schizophrenia. Methods 60 inpatients with chronic schizophrenia who took clozapine were treated by risperidone for 12 weeks. Effects and side effects were assessed with PANSS and TESS respectively before and after 4, 8, 12 weeks treatment. Results Risperdone was as effective as clozapine in the treatment of schizophrenia, after 12 weeks treatment there were no significant differences in the positive score of PANSS and total score (t=1.52, t=1.59, P0.05), and there was significant differences in the negative score of PANSS (t=6.13, P 0.01), Risperidone replacement could further improve negative symptoms and less side effects than clozapine. Conclusion Rispredone replacing clozapine is effective in the treatment of chronic schizophrenia with less side effects and good compliance.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To compare the efficacy and safety of rispredone and Clozapine in the treatment of chronic schizophrenia. Methods 60 inpatients with chronic schizophrenia who took clozapine were treated by risperidone for 12 weeks. Effects and side effects were assessed with PANSS and TESS respectively before and after 4, 8, 12 weeks treatment. Results Risperdone was as effective as clozapine in the treatment of schizophrenia, after 12 weeks treatment there were no significant differences in the positive score of PANSS and total score (t=1.52, t=1.59, P0.05), and there was significant differences in the negative score of PANSS (t=6.13, P 0.01), Risperidone replacement could further improve negative symptoms and less side effects than clozapine. Conclusion Rispredone replacing clozapine is effective in the treatment of chronic schizophrenia with less side effects and good compliance.

Key concepts: Clozapine, Risperidone, Schizophrenia (object-oriented programming), Medicine, Internal medicine, Side effect (computer science), Psychiatry, Psychology

Related papers

Back to paper searchBrowse research topicsOriginal source
The Clinical Study on Risperidone Replacing Clozapine in the Treatment of Chronic Schizophrenia — Research Paper | ScholarLens